Nordson Corporation Sees 8.5% Share Drop

On Thursday, Nordson (NASDAQ:NDSN) Corporation, a manufacturer of industrial equipment, experienced an 8.5% decline in shares. This decline was attributed to the company's full-year guidance, which analysts considered weak.

Despite solid results, Nordson provided a conservative outlook for Fiscal Year 2025, citing a lower backlog and cautious customer spending. The company enters FY25 with a reduced backlog of $580 million, down from $800 million at the year's start, indicating a book-to-bill ratio of approximately 0.9x in the fourth quarter.

Analysts from Jefferies maintained a 'hold' rating, citing the disappointing FY25 guidance. KeyBanc Capital Markets, echoing a 'sector weight' rating, expressed disappointment due to a significant decline in the backlog. However, DA Davidson maintains a 'buy' rating, noting that sales and adjusted operating profit exceeded expectations.

Nordson's forecast for FY25 includes an adjusted EPS range of $9.70 to $10.50, which is below the Bloomberg Consensus estimate of $10.39. The company anticipates first-quarter FY25 sales between $615 million and $655 million, notably lower than the estimated $678.8 million, and an adjusted EPS of $1.95 to $2.15.

The fourth-quarter results indicated an adjusted EPS of $2.78 with sales rising 3.5% year-over-year to $744.5 million, surpassing the estimated $736.2 million. While sales for industrial precision solutions decreased by 3.3% year-over-year, advanced technology solutions sales grew by 4.7%. Total operating profit declined by 3.3% year-over-year.

Reflecting on these results, Nordson's CEO mentioned the conservative approach for FY25 due to the changing global macro-environment and the anticipated seasonal slowdown in the first quarter. Despite this cautious outlook, confidence in long-term growth drivers remains, especially after the successful integration of Atrion Medical (TASE:PMCN), which positively influenced the quarter. With a diversified portfolio and leadership in niche markets, Nordson is expected to deliver balanced results amid macro challenges. The company is also focused on its Ascend strategy goals of achieving $3 billion in annual sales and over 30% EBITDA margins by 2025.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.